Anti-EGFR-miniantibody-barnase immunoconjugate is highly toxic for human tumor cells

By Edelweiss E.   Balandin T.   Stremovskiy O.   Deyev S.   Petrov R.  

Doklady Biochemistry & Biophysics, Vol. 434, Iss. 1, 2010-10 ,pp. : 270-273

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies

By Cui Dandan   Cao Dan   Yang Yu   Qiu Meng   Huang Ying   Yi Cheng  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1291-1298

Springer Publishing Company

Access to resources Recommend Favorite

Differential Phosphoprofiles of EGF and EGFR Kinase Inhibitor-Treated Human Tumor Cells and Mouse Xenografts

By Stover David R.   Caldwell Jennifer   Marto Jarrod   Root Karen   Mestan Juergan   Stumm Michael   Ornatsky Olga   Orsi Chris   Radosevic Nina   Liao Linda   Fabbro Doriano   Moran MichaelF.  

Clinical Proteomics, Vol. 1, Iss. 1, 2004-03 ,pp. : 69-80

Humana Press, Inc

Access to resources Recommend Favorite

BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis

By Mao Chen   Liao Ru-Yan   Qiu Li-Xin   Wang Xi-Wen   Ding Hong   Chen Qing  

Molecular Biology Reports, Vol. 38, Iss. 4, 2011-04 ,pp. : 2219-2223

Springer Publishing Company

Access to resources Recommend Favorite

Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition

By McKillop D.   Guy S. P.   Spence M. P.   Kendrew J.   Kemp J. V.   Bushby N.   Wood P. G.   Barnett S.   Hutchison M.  

Xenobiotica, Vol. 36, Iss. 1, 2006-01 ,pp. : 29-39

Informa Healthcare

Access to resources Recommend Favorite